Charles River Laboratories | CRL - 流动资产



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 11.66B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


流动资产 更改 日
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Cardinal Health USD 38.06B 1.17B 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cigna USD 43.03B 4.78B 2026-03
Concord Medical Services Hldg CNY 1.03B 174.49M 2025-06
CVS Health USD 74.82B 103M 2026-03
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.85B 178M 2026-03
Elevance Health USD 67.18B 152M 2026-06
Humana USD 38.08B 5.35B 2026-03
Illumina USD 2.74B 551M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.22B 29M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Lonza CHF 8B 3.41B 2025-12
McKesson USD 57.21B 2.49B 2026-03
Merck EUR 14.16B 932M 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Quest Diagnostics USD 2.84B 278M 2026-06
Revvity USD 2.13B 111.43M 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
United Therapeutics USD 2.87B 830.5M 2026-03
UnitedHealth USD 91.13B 545M 2026-03
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.72B 1.73B 2026-03
West Pharmaceutical Services USD 1.81B 19.3M 2026-06